Gilad Halpert
Impact in
- Toxicology top 2%
- Organoselenium and organotellurium chemistry
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
- Rheumatology 11
- Systemic Lupus Erythematosus Research 9
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 5
- Co-authors
- Yehuda Shoenfeld (25 shared papers)Arad Dotan (4 shared papers)Sylviane Muller (2 shared papers)Darja Kanduc (1 shared paper)Paula David (1 shared paper)Benjamin Sredni (4 shared papers)Howard Amital (23 shared papers)Michael Albeck (2 shared papers)
- Journals
- Autoimmunity Reviews (4 papers)Clinical & Experimental Immunology (3 papers)Biomolecules (2 papers)Brain Behavior & Immunity - Health (1 paper)Immunologic Research (1 paper)
- Partner nations
- IsraelRussiaUnited States
In The Last Decade
Gilad Halpert
44 papers receiving 1.3k citations
Gilad Halpert's Hit Papers
Peers
Comparison fields: 5 of 91
- Toxicology 93
- Rheumatology 219
- Neurology 216
- Infectious Diseases 279
- Pharmaceutical Science 68
Countries citing papers authored by Gilad Halpert
This map shows the geographic impact of Gilad Halpert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilad Halpert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilad Halpert more than expected).
Fields of papers citing papers by Gilad Halpert
This network shows the impact of papers produced by Gilad Halpert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilad Halpert. The network helps show where Gilad Halpert may publish in the future.
Co-authors
The 25 scholars most cited alongside Gilad Halpert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The SARS-CoV-2 as an instrumental trigger of autoimmunity Hit paper breakdown → | 2021 | 375 |
| 2 | 2020 | 135 | |
| 3 | 2022 | 100 | |
| 4 | 2018 | 94 | |
| 5 | 2018 | 76 | |
| 6 | 2023 | 76 | |
| 7 | 2020 | 63 | |
| 8 | 2014 | 61 | |
| 9 | 2010 | 52 | |
| 10 | 2014 | 31 | |
| 11 | 2023 | 31 | |
| 12 | 2021 | 28 | |
| 13 | 2023 | 23 | |
| 14 | 2017 | 22 | |
| 15 | 2023 | 21 | |
| 16 | 2023 | 20 | |
| 17 | 2021 | 19 | |
| 18 | The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium. | 2016 | 17 |
| 19 | 2011 | 14 | |
| 20 | 2019 | 12 |
About Gilad Halpert
Gilad Halpert is a scholar working on Rheumatology, Infectious Diseases, Surgery, Toxicology and Endocrinology, Diabetes and Metabolism, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (9 papers), Breast Implant and Reconstruction (8 papers), COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Inflammatory Bowel Disease (5 papers), Adrenal Hormones and Disorders (4 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers). The work is most often cited by research in Toxicology (93 citations), Rheumatology (219 citations), Neurology (216 citations), Infectious Diseases (279 citations) and Pharmaceutical Science (68 citations). Gilad Halpert has collaborated with scholars based in Israel, Russia and United States. Frequent co-authors include Yehuda Shoenfeld, Arad Dotan, Sylviane Muller, Darja Kanduc, Paula David, Benjamin Sredni, Howard Amital, Michael Albeck, Abdulla Watad and Xinglu Huang. Their work appears in journals such as Autoimmunity Reviews, Clinical & Experimental Immunology, Biomolecules, Brain Behavior & Immunity - Health and Immunologic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.